Edward Tenthoff

Stock Analyst at Piper Sandler

(0)
# 4296
Out of 5,240 analysts
224
Total ratings
34.16%
Success rate
-9.48%
Average return
64 Stocks
Name Action Price Target Current % Upside Ratings Updated
Legend Biotech
Reiterates: Overweight
78 78
31.6 146.84% 4 Dec 30, 2024
Century Therapeutics
Maintains: Overweight
12 4
0.96 316.67% 7 Dec 30, 2024
Mesoblast
Maintains: Overweight
11 15
16.68 -10.07% 4 Dec 19, 2024
Xencor
Upgrades: Overweight
20 30
19.64 52.75% 4 Dec 2, 2024
Arrowhead Pharma
Maintains: Overweight
62 45
18.51 143.11% 10 Nov 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
296 296
250.03 18.39% 7 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
115 69
34.71 98.79% 12 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
9 4
0.63 534.92% 5 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
6 1
0.97 3.09% 7 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
8 5
0.88 468.18% 4 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
18
3.74 381.28% 1 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
35
12.98 169.65% 1 Oct 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
11 11
1.79 514.53% 6 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
53 53
15.14 250.07% 5 Sep 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
20 20
n/a n/a 3 Sep 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
3 3
1.49 101.34% 6 Sep 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
13 5
0.22 2172.73% 6 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
8 3
1.28 134.38% 4 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
16 16
6.04 164.9% 3 Jun 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
105 105
39.72 164.35% 6 Jun 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
4 6
1.33 351.13% 7 Jun 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
5 5
0.2 2400% 4 Apr 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
120 80
n/a n/a 5 Mar 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
6 5
1.99 151.26% 4 Mar 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
13 15
4.12 264.08% 3 Feb 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
39 56
41.17 36.02% 4 Feb 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
8 10
n/a n/a 3 Dec 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
5 2
n/a n/a 2 Nov 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
13
n/a n/a 2 Oct 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
70 55
17.74 210.03% 6 Oct 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
6 7
n/a n/a 2 Sep 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
28 31
1.15 2595.65% 5 Aug 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
6 1
0.05 900% 2 Aug 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
13 20
n/a n/a 5 Jul 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 4 Feb 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
6 5
n/a n/a 3 Jan 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
3
0.47 538.3% 1 Dec 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
6 2
n/a n/a 1 Nov 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
13 6
0.78 669.23% 4 Nov 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
7 9
0.78 1053.85% 3 Sep 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
37 44
17.88 146.09% 1 Aug 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
160 60
n/a n/a 2 May 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
76 37
14.59 153.6% 2 May 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
175 100
n/a n/a 2 May 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
112332 32560
4.53 718663.8% 3 May 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
250 354
661.93 -46.52% 4 Nov 29, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
105 135
1.43 9340.56% 2 Sep 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
261 323
419.49 -23% 6 Jul 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
80 25
n/a n/a 3 May 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
33 36
36.33 -0.91% 2 Feb 16, 2021